These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18432490)

  • 1. An introduction to decision analysis in the economic evaluation of the prevention and treatment of vision-related diseases.
    Kymes SM
    Ophthalmic Epidemiol; 2008; 15(2):76-83. PubMed ID: 18432490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness.
    Lichter PR
    Ophthalmology; 2008 Oct; 115(10):1852-3; author reply 1853. PubMed ID: 18929170
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of treating ocular hypertension.
    Stewart WC; Stewart JA; Nasser QJ; Mychaskiw MA
    Ophthalmology; 2008 Jan; 115(1):94-8. PubMed ID: 18166406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness.
    Tuulonen A; Azuara-Blanco A
    Ophthalmology; 2009 Jan; 116(1):166-7; author reply 167. PubMed ID: 19118707
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness.
    Brown GC; Brown MM
    Ophthalmology; 2008 Aug; 115(8):1433; author reply 1433-4. PubMed ID: 18675701
    [No Abstract]   [Full Text] [Related]  

  • 6. The increased cost of medical services for people diagnosed with primary open-angle glaucoma: a decision analytic approach.
    Kymes SM; Plotzke MR; Li JZ; Nichol MB; Wu J; Fain J
    Am J Ophthalmol; 2010 Jul; 150(1):74-81. PubMed ID: 20493465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized model of cost-utility analysis for treatment of age-related macular degeneration.
    Fletcher EC; Lade RJ; Adewoyin T; Chong NV
    Ophthalmology; 2008 Dec; 115(12):2192-8. PubMed ID: 18930556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with ocular hypertension: a cost-effectiveness approach from the Ocular Hypertension Treatment Study.
    Rosenbaum LJ
    Am J Ophthalmol; 2007 Jan; 143(1):191-2; author reply 192-3. PubMed ID: 17188074
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost-effectiveness of treatment of age-related macular degeneration: a review.
    Kymes Steven M
    Minerva Med; 2009 Feb; 100(1):69-78. PubMed ID: 19277005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United States.
    Rein DB; Wittenborn JS; Lee PP; Wirth KE; Sorensen SW; Hoerger TJ; Saaddine JB
    Ophthalmology; 2009 May; 116(5):823-32. PubMed ID: 19285730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allocating resources for cancer control--resolving multicriteria decision-making using the analytic hierarchy process].
    Gróf A
    Magy Onkol; 2007; 51(3):197-208. PubMed ID: 17922059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. It is money that matters: decision analysis and cost-effectiveness analysis.
    Kocher MS; Henley MB
    Clin Orthop Relat Res; 2003 Aug; (413):106-16. PubMed ID: 12897601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation for ophthalmologists.
    Kuper H; Jofre-Bonet M; Gilbert C
    Ophthalmic Epidemiol; 2006 Dec; 13(6):393-401. PubMed ID: 17169853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and health economic assessments of age-related macular degeneration.
    Covert D; Berdeaux G; Mitchell J; Bradley C; Barnes R
    Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S20-5. PubMed ID: 17240252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glaucoma care cost-effectiveness.
    Hoskins HD
    Ophthalmology; 2009 May; 116(5):1016. PubMed ID: 19410965
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
    Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an example.
    Weintraub WS
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):107-19. PubMed ID: 18495905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of vision for vitreoretinal interventions.
    Smiddy WE
    Curr Opin Ophthalmol; 2008 May; 19(3):195-201. PubMed ID: 18408493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.